Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel

This study has been withdrawn prior to enrollment.
(Slow accrual.)
Sponsor:
Collaborator:
Allergan
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00824811
First received: January 16, 2009
Last updated: August 1, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given